The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Phospholipase A2 domain
".
FunFam 1: Basic phospholipase A2 homolog
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 17 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Phospholipase A2 activity GO:0004623
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate.
|
13 |
A8E2V8 (/IDA)
P00625 (/IDA)
P14555 (/IDA)
P14555 (/IDA)
P86169 (/IDA)
P86803 (/IDA)
P86804 (/IDA)
P86805 (/IDA)
P86806 (/IDA)
P86907 (/IDA)
(3 more) |
Phospholipase A2 activity GO:0004623
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate.
|
4 | O15496 (/TAS) P14423 (/TAS) Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
3 | P51433 (/IDA) Q9WVF6 (/IDA) Q9WVF6 (/IDA) |
Calcium-dependent phospholipase A2 activity GO:0047498
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. This reaction requires Ca2+.
|
3 | P14555 (/TAS) P14555 (/TAS) P39877 (/TAS) |
Phospholipid binding GO:0005543
Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester.
|
2 | P14555 (/IDA) P14555 (/IDA) |
Heparan sulfate proteoglycan binding GO:0043395
Interacting selectively and non-covalently with a heparan sulfate proteoglycan, any proteoglycan containing heparan sulfate as the glycosaminoglycan carbohydrate unit.
|
2 | Q9WVF6 (/IDA) Q9WVF6 (/IDA) |
Calcium-dependent phospholipase A2 activity GO:0047498
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. This reaction requires Ca2+.
|
2 | P14423 (/IDA) P51433 (/IDA) |
Phospholipase activity GO:0004620
Catalysis of the hydrolysis of a glycerophospholipid.
|
1 | Q9QXX3 (/IMP) |
Phospholipase activity GO:0004620
Catalysis of the hydrolysis of a glycerophospholipid.
|
1 | O15496 (/ISS) |
Phospholipase A2 activity GO:0004623
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate.
|
1 | Q9QXX3 (/ISO) |
Phospholipase A2 activity GO:0004623
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate.
|
1 | Q9BZM2 (/NAS) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | P97391 (/IPI) |
Calcium ion binding GO:0005509
Interacting selectively and non-covalently with calcium ions (Ca2+).
|
1 | P86169 (/IDA) |
Calcium ion binding GO:0005509
Interacting selectively and non-covalently with calcium ions (Ca2+).
|
1 | A8E2V8 (/NAS) |
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
1 | P97391 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
1 | P82896 (/IPI) |
Calcium-dependent phospholipase A2 activity GO:0047498
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. This reaction requires Ca2+.
|
1 | P97391 (/ISO) |
There are 70 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Phospholipid metabolic process GO:0006644
The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester.
|
8 | A8E2V8 (/IDA) P00625 (/IDA) P14423 (/IDA) P14555 (/IDA) P14555 (/IDA) P86907 (/IDA) P97391 (/IDA) Q9QZT4 (/IDA) |
Phosphatidic acid biosynthetic process GO:0006654
The chemical reactions and pathways resulting in the formation of phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids.
|
7 | O15496 (/TAS) P14555 (/TAS) P14555 (/TAS) P39877 (/TAS) Q9BZM2 (/TAS) Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Phosphatidylglycerol acyl-chain remodeling GO:0036148
Remodeling the acyl chains of phosphatidylglycerol, through sequential deacylation and re-acylation reactions, to generate phosphatidylglycerol containing different types of fatty acid acyl chains.
|
7 | O15496 (/TAS) P14555 (/TAS) P14555 (/TAS) P39877 (/TAS) Q9BZM2 (/TAS) Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Phosphatidylinositol acyl-chain remodeling GO:0036149
Remodeling the acyl chains of phosphatidylinositol, through sequential deacylation and re-acylation reactions, to generate phosphatidylinositol containing different types of fatty acid acyl chains.
|
7 | O15496 (/TAS) P14555 (/TAS) P14555 (/TAS) P39877 (/TAS) Q9BZM2 (/TAS) Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Phosphatidylserine acyl-chain remodeling GO:0036150
Remodeling the acyl chains of phosphatidylserine, through sequential deacylation and re-acylation reactions, to generate phosphatidylserine containing different types of fatty acid acyl chains.
|
7 | O15496 (/TAS) P14555 (/TAS) P14555 (/TAS) P39877 (/TAS) Q9BZM2 (/TAS) Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Phosphatidylcholine acyl-chain remodeling GO:0036151
Remodeling the acyl chains of phosphatidylcholine, through sequential deacylation and re-acylation reactions, to generate phosphatidylcholine containing different types of fatty acid acyl chains.
|
7 | O15496 (/TAS) P14555 (/TAS) P14555 (/TAS) P39877 (/TAS) Q9BZM2 (/TAS) Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Phosphatidylethanolamine acyl-chain remodeling GO:0036152
Remodeling the acyl chains of phosphatidylethanolamine, through sequential deacylation and re-acylation reactions, to generate phosphatidylethanolamine containing different types of fatty acid acyl chains.
|
7 | O15496 (/TAS) P14555 (/TAS) P14555 (/TAS) P39877 (/TAS) Q9BZM2 (/TAS) Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Pathogenesis GO:0009405
The set of specific processes that generate the ability of an organism to induce an abnormal, generally detrimental state in another organism.
|
6 | P86169 (/IDA) P86453 (/IDA) P86803 (/IDA) P86804 (/IDA) P86805 (/IDA) P86806 (/IDA) |
Envenomation resulting in induction of edema in other organism GO:0044398
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the swelling of soft tissues of the bitten organism as a result of excess water accumulation.
|
5 | P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) |
Envenomation resulting in positive regulation of platelet aggregation in other organism GO:0044478
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the resultant activation, maintenance or an increase in the frequency, rate or extent of platelet aggregation in the bitten organism.
|
5 | P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) |
Envenomation resulting in muscle damage in other organism GO:0044521
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with resultant muscle damage in the bitten organism.
|
5 | P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) |
Envenomation resulting in modulation of apoptotic process in other organism GO:0044534
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the resultant modulation of apoptosis in the bitten organism.
|
5 | P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) P62022 (/IDA) |
Phospholipid catabolic process GO:0009395
The chemical reactions and pathways resulting in the breakdown of phospholipids, any lipid containing phosphoric acid as a mono- or diester.
|
4 | P86803 (/IDA) P86804 (/IDA) P86805 (/IDA) P86806 (/IDA) |
Cytolysis in other organism GO:0051715
The killing by an organism of a cell in another organism by means of the rupture of cell membranes and the loss of cytoplasm.
|
4 | P86803 (/IDA) P86804 (/IDA) P86805 (/IDA) P86806 (/IDA) |
Phospholipid metabolic process GO:0006644
The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester.
|
3 | P39877 (/TAS) Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Lipid catabolic process GO:0016042
The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
|
3 | A8E2V8 (/IDA) P00625 (/IDA) P86907 (/IDA) |
Low-density lipoprotein particle remodeling GO:0034374
The acquisition, loss or modification of a protein or lipid within a low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.
|
3 | P97391 (/IMP) Q9QUL3 (/IMP) Q9QUL3 (/IMP) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
3 | Q9QZT4 (/IDA) Q9WVF6 (/IDA) Q9WVF6 (/IDA) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
3 | P14555 (/IDA) P14555 (/IDA) P39877 (/IDA) |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation GO:0002361
The process in which a precursor cell type acquires the specialized features of a CD4-positive, CD25-positive, alpha-beta regulatory T cell.
|
2 | Q9WVF6 (/IDA) Q9WVF6 (/IDA) |
Regulation of muscle contraction GO:0006937
Any process that modulates the frequency, rate or extent of muscle contraction.
|
2 | P86803 (/IDA) P86804 (/IDA) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | Q9NZK7 (/TAS) Q9UNK4 (/TAS) |
Positive regulation of macrophage derived foam cell differentiation GO:0010744
Any process that increases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
|
2 | P14555 (/TAS) P14555 (/TAS) |
Antimicrobial humoral response GO:0019730
An immune response against microbes mediated through a body fluid. Examples of this process are seen in the antimicrobial humoral response of Drosophila melanogaster and Mus musculus.
|
2 | P14555 (/TAS) P14555 (/TAS) |
Low-density lipoprotein particle remodeling GO:0034374
The acquisition, loss or modification of a protein or lipid within a low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.
|
2 | P14555 (/TAS) P14555 (/TAS) |
Regulation of macrophage activation GO:0043030
Any process that modulates the frequency or rate of macrophage activation.
|
2 | O15496 (/IMP) P97391 (/IMP) |
Phosphatidic acid metabolic process GO:0046473
The chemical reactions and pathways involving phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids.
|
2 | P14555 (/IDA) P14555 (/IDA) |
Arachidonic acid secretion GO:0050482
The controlled release of arachidonic acid from a cell or a tissue.
|
2 | P51433 (/IDA) P97391 (/IDA) |
Positive regulation of inflammatory response GO:0050729
Any process that activates or increases the frequency, rate or extent of the inflammatory response.
|
2 | P14555 (/TAS) P14555 (/TAS) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
2 | P14555 (/TAS) P14555 (/TAS) |
Negative regulation of T cell activation GO:0050868
Any process that stops, prevents, or reduces the frequency, rate or extent of T cell activation.
|
2 | Q9WVF6 (/IDA) Q9WVF6 (/IDA) |
Platelet activating factor biosynthetic process GO:0006663
The chemical reactions and pathways resulting in the formation of platelet activating factor, 1-O-alkyl-2-acetyl-sn-glycerol 3-phosphocholine, where alkyl = hexadecyl or octadecyl. Platelet activating factor is an inflammatory mediator released from a variety of cells in response to various stimuli.
|
1 | P51433 (/IDA) |
Platelet activating factor biosynthetic process GO:0006663
The chemical reactions and pathways resulting in the formation of platelet activating factor, 1-O-alkyl-2-acetyl-sn-glycerol 3-phosphocholine, where alkyl = hexadecyl or octadecyl. Platelet activating factor is an inflammatory mediator released from a variety of cells in response to various stimuli.
|
1 | P97391 (/ISO) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
1 | O15496 (/IDA) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
1 | Q9QXX3 (/ISO) |
Positive regulation of phospholipase activity GO:0010518
Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
|
1 | P39877 (/IDA) |
Positive regulation of phospholipase activity GO:0010518
Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
|
1 | P97391 (/ISO) |
Positive regulation of macrophage derived foam cell differentiation GO:0010744
Any process that increases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
|
1 | O15496 (/IC) |
Positive regulation of lipid storage GO:0010884
Any process that increases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
|
1 | O15496 (/IMP) |
Positive regulation of lipid storage GO:0010884
Any process that increases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
|
1 | Q9QXX3 (/ISO) |
Lipid catabolic process GO:0016042
The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
|
1 | P14423 (/TAS) |
Arachidonic acid metabolic process GO:0019369
The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
|
1 | O15496 (/NAS) |
Leukotriene biosynthetic process GO:0019370
The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.
|
1 | P51433 (/IDA) |
Leukotriene biosynthetic process GO:0019370
The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.
|
1 | P97391 (/ISO) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
1 | O15496 (/IMP) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
1 | Q9QXX3 (/ISO) |
Positive regulation of prostaglandin secretion GO:0032308
Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell.
|
1 | O15496 (/IMP) |
Positive regulation of prostaglandin secretion GO:0032308
Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell.
|
1 | Q9QXX3 (/ISO) |
Response to cytokine GO:0034097
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
1 | P51433 (/IEP) |
Cholesterol homeostasis GO:0042632
Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
|
1 | Q9QXX3 (/IMP) |
Cholesterol homeostasis GO:0042632
Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
|
1 | O15496 (/ISS) |
Regulation of macrophage activation GO:0043030
Any process that modulates the frequency or rate of macrophage activation.
|
1 | Q9QXX3 (/ISO) |
Negative regulation of DNA-binding transcription factor activity GO:0043433
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
1 | O15496 (/IDA) |
Negative regulation of DNA-binding transcription factor activity GO:0043433
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
1 | Q9QXX3 (/IMP) |
Negative regulation of DNA-binding transcription factor activity GO:0043433
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
1 | Q9QXX3 (/ISO) |
Envenomation resulting in negative regulation of platelet aggregation in other organism GO:0044477
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the resultant stopping, prevention or reduction in the frequency, rate or extent of platelet aggregation in the bitten organism.
|
1 | A8E2V8 (/IDA) |
Positive regulation of cytolysis GO:0045919
Any process that activates or increases the frequency, rate or extent of cytolysis.
|
1 | P86453 (/IDA) |
Negative regulation of muscle contraction GO:0045932
Any process that stops, prevents, or reduces the frequency, rate or extent of muscle contraction.
|
1 | P86453 (/IDA) |
Arachidonic acid secretion GO:0050482
The controlled release of arachidonic acid from a cell or a tissue.
|
1 | P97391 (/ISO) |
Negative regulation of inflammatory response GO:0050728
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
|
1 | P97391 (/IMP) |
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
|
1 | P86169 (/IDA) |
Response to cAMP GO:0051591
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
1 | P51433 (/IEP) |
Lysophospholipid transport GO:0051977
The directed movement of phospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A lysophospholipid is a phospholipid that lacks one of its fatty acyl chains; it is an intermediate formed during digestion of dietary and biliary phospholipids.
|
1 | O15496 (/IDA) |
Lysophospholipid transport GO:0051977
The directed movement of phospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A lysophospholipid is a phospholipid that lacks one of its fatty acyl chains; it is an intermediate formed during digestion of dietary and biliary phospholipids.
|
1 | Q9QXX3 (/ISO) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
1 | P97391 (/ISO) |
Positive regulation of arachidonic acid secretion GO:0090238
Any process that increases the rate, frequency, or extent of arachidonic acid secretion, the controlled release of arachidonic acid from a cell or a tissue.
|
1 | Q9QXX3 (/IDA) |
Positive regulation of arachidonic acid secretion GO:0090238
Any process that increases the rate, frequency, or extent of arachidonic acid secretion, the controlled release of arachidonic acid from a cell or a tissue.
|
1 | O15496 (/ISS) |
Negative regulation of cholesterol efflux GO:0090370
Any process that decreases the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
|
1 | Q9QXX3 (/IDA) |
Negative regulation of cholesterol efflux GO:0090370
Any process that decreases the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
|
1 | O15496 (/ISS) |
Cellular response to leukemia inhibitory factor GO:1990830
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
|
1 | Q9QXX3 (/IEP) |
There are 19 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
11 |
P62022 (/IDA)
P62022 (/IDA)
P62022 (/IDA)
P62022 (/IDA)
P62022 (/IDA)
P86169 (/IDA)
P86453 (/IDA)
P86803 (/IDA)
P86804 (/IDA)
P86805 (/IDA)
(1 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
10 | A8E2V8 (/TAS) O15496 (/TAS) P00625 (/TAS) P14555 (/TAS) P14555 (/TAS) P39877 (/TAS) Q9BZM2 (/TAS) Q9NZK7 (/TAS) Q9QZT3 (/TAS) Q9UNK4 (/TAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
3 | O15496 (/IDA) P14555 (/IDA) P14555 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P14555 (/HDA) P14555 (/HDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
2 | P14555 (/IDA) P14555 (/IDA) |
Endoplasmic reticulum membrane GO:0005789
The lipid bilayer surrounding the endoplasmic reticulum.
|
2 | P14555 (/TAS) P14555 (/TAS) |
Extracellular space of host GO:0043655
The space within a host but external to the plasma membrane of host cells, e.g. within host bloodstream.
|
2 | A8E2V8 (/TAS) P00625 (/TAS) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
2 | P14423 (/IDA) P51433 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
2 | P14555 (/HDA) P14555 (/HDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | Q9BZM2 (/NAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | Q9QXX3 (/ISO) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
1 | P51433 (/IDA) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
1 | P97391 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | Q9BZM2 (/TAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | P51433 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | P97391 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
1 | P97391 (/IDA) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
1 | P14423 (/IDA) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
1 | P97391 (/ISO) |